Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HBL-5 |
Target |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), PLK1 inhibitors(Polo like kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H57N9O11 |
InChIKeyGLNZQWXKBMEKNA-BONSOQDYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | - |